TC
VCNX

Tacita Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Tacita Capital’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-228
Closed -$1.69K – 222
2024
Q1 		$1.69K Buy
+228
New +$1.98K ﹤0.01% 206
2023
Q4 		– Sell
-227
Closed -$3.55K – 226
2023
Q3 		$3.55K Buy
+227
New +$11.5K ﹤0.01% 186
2021
Q4 		– Sell
-65
Closed -$29K – 201
2021
Q3 		$29K Hold
65
– – 0.02% 157
2021
Q2 		$38K Hold
65
– – 0.02% 158
2021
Q1 		$40K Hold
65
– – 0.03% 159
2020
Q4 		$28K Buy
+65
New +$27.2K 0.02% 163

Other funds holding VCNX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Tacita Capital's VCNX Position: Q2 2024 in Review

Tacita Capital sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2024, closing a stake of 228 shares — an estimated $1.69K sold.

Tacita Capital first reported a position in VCNX in Q4 2020 and held it in 6 quarters. The position peaked at $40K in Q1 2021. 11 funds tracked by Wall St. Rank hold VCNX as of Q2 2024.

  • Tacita Capital reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tacita Capital sold 228 Vaccinex, Inc. Common Stock shares in Q2 2024, an estimated $1.69K.
  • Tacita Capital first reported a position in Vaccinex, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Tacita Capital's Vaccinex, Inc. Common Stock position peaked at $40K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2024.

Based on Tacita Capital's 13F filing for Q2 2024, filed 8 Aug 2024.